Pharmafile Logo
Pharmafocus logo
Advanced Search

LaNova Medicines

Showing 1 posts of 1 posts found.

LaNova Medicines and AstraZeneca sign global exclusive license agreement for preclinical ADC

May 15, 2023
Research and Development ADC, AstraZeneca, LaNova Medicines, License Agreement, Oncology

Chinese biotechnology company LaNova Medicines and UK-based pharma company AstraZeneca have announced that they have signed a global exclusive license …

News
The Gateway to Local Adoption Series

Latest content

Care Quality Commission appoints Emily Miles as Chief Executive

July 17, 2026

National survey aims to improve glaucoma care across the UK

July 16, 2026

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026